FTC sues big pharmacy profit managers in excess of insulin charges The agency brought motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the checklist cost of lifetime-saving insulin drugs. Sanders swiftly condemned the transfer in a statement Wednesday, noting he was https://kethek.com/